Header cover image

U.S. Pharmaceuticals & Biotech Potentially Undervalued Companies

UPDATED May 20, 2022

Companies with a Value score of at least 3, ordered by Value score

209 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
CPHR.FCipher PharmaceuticalsUS$1.82-3.3%51.5%US$60.8mUS$2.66PS5.5xE7.9%n/a
APNH.FAspen Pharmacare HoldingsUS$10.750%n/aUS$71.4bUS$16.82PS12.1xE20.4%1.7%
QUREuniQureUS$13.72-4.1%-59.6%US$625.5mUS$53.71PS2xE22.5%n/a
APNH.YAspen Pharmacare HoldingsUS$9.610.1%-19.0%US$71.4bUS$15.04PS12.1xE20.4%1.7%
GEDS.FRichter Gedeon Vegyészeti Gyár Nyilvánosan Muködo RtUS$20.906.1%n/aUS$1.4tUS$24.33PS10xE16.4%3.0%
RGED.FRichter Gedeon Vegyészeti Gyár Nyilvánosan Muködo RtUS$24.6325.0%-15.1%US$1.4tUS$28.67PS10xE16.4%3.0%
EBSEmergent BioSolutionsUS$35.3322.9%-39.6%US$1.6bUS$44.50PS11.3xE21.2%n/a
CHIZ.FChina Traditional Chinese Medicine HoldingsUS$0.460%n/aUS$19.7bn/aPS8.7xE13.6%3.6%
AVIRAtea PharmaceuticalsUS$7.492.7%-66.6%US$603.6mUS$10.25PS12.9xE45.3%n/a
CSWY.FChina Shineway Pharmaceutical GroupUS$0.730%n/aUS$4.5bn/aPS7xE10.3%7.6%
ULIH.FUnited Laboratories International HoldingsUS$0.500%n/aUS$6.8bn/aPS5.8xE9.0%5.0%
KDCEKid Castle EducationalUS$0.050%n/aUS$1.1mn/an/an/an/a
PHMM.FPharma MarUS$77.000%-21.2%US$1.3bUS$87.24PS13.9xE23.3%0.9%
SNPH.YSanten PharmaceuticalUS$7.88-1.1%-40.3%US$403.1bUS$11.55PS14.8xE2.5%3.2%
SNPH.FSanten PharmaceuticalUS$7.80-3.4%-40.9%US$403.1bUS$11.44PS14.8xE2.5%3.2%
HALOHalozyme TherapeuticsUS$44.329.6%5.0%US$6.0bUS$49.13PS14xE15.9%n/a
COLLCollegium PharmaceuticalUS$16.364.6%-34.6%US$542.9mUS$28.86PS13xE33.1%n/a
YOUR.FYourWay Cannabis BrandsUS$0.0829.0%-58.5%US$23.2mn/aPS6.1xn/an/a
GNML.FGenomma Lab Internacional. deUS$1.03-8.0%0%US$20.9bUS$1.29PS14.2xE16.1%1.8%
HYPM.YHyperaUS$8.3012.6%24.8%US$23.3bUS$9.81PS14xE18.3%3.3%
SOLC.FSOL Global InvestmentsUS$0.55-15.6%-81.0%US$33.5mn/an/an/an/a
RGNXREGENXBIOUS$20.08-3.6%-42.8%US$847.6mUS$51.33PS8.6xE-18.2%n/a
ORGOOrganogenesis HoldingsUS$5.98-3.1%-63.6%US$760.6mUS$14.00PS9.1xE10.1%n/a
QPTF.FQuest PharmaTechUS$0.070%-30.1%US$16.0mn/an/an/an/a
Page 1 of 9